NeoMutate: an ensemble machine learning framework for the prediction of somatic mutations in cancer.

Journal: BMC medical genomics
Published Date:

Abstract

BACKGROUND: The accurate screening of tumor genomic landscapes for somatic mutations using high-throughput sequencing involves a crucial step in precise clinical diagnosis and targeted therapy. However, the complex inherent features of cancer tissue, especially, tumor genetic intra-heterogeneity coupled with the problem of sequencing and alignment artifacts, makes somatic variant calling a challenging task. Current variant filtering strategies, such as rule-based filtering and consensus voting of different algorithms, have previously helped to increase specificity, although comes at the cost of sensitivity.

Authors

  • Irantzu Anzar
    OncoImmunity AS, Oslo Cancer Cluster, Ullernchausseen 64/66, 0379, Oslo, Norway.
  • Angelina Sverchkova
    OncoImmunity AS, Oslo Cancer Cluster, Ullernchausseen 64/66, 0379, Oslo, Norway.
  • Richard Stratford
    NEC OncoImmunity AS, Oslo, Norway.
  • Trevor Clancy
    NEC OncoImmunity AS, Oslo, Norway.